Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
13.8M
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
7.08M
-
Shares change
-
+93.6K
-
Total reported value, excl. options
-
$65.5M
-
Value change
-
+$877K
-
Number of buys
-
13
-
Number of sells
-
-21
-
Price
-
$9.25
Significant Holders of CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) as of Q3 2020
48 filings reported holding CSBR - CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share as of Q3 2020.
CHAMPIONS ONCOLOGY, INC. - Common Stock, par value $0.001 per share (CSBR) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.08M shares
of 13.8M outstanding shares and own 51.2% of the company stock.
Largest 10 shareholders include Battery Partners IX, LLC (2.42M shares), NEA Management Company, LLC (1.71M shares), VANGUARD GROUP INC (646K shares), BlackRock Inc. (450K shares), TOCQUEVILLE ASSET MANAGEMENT L.P. (252K shares), RENAISSANCE TECHNOLOGIES LLC (240K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (144K shares), DIMENSIONAL FUND ADVISORS LP (132K shares), Millrace Asset Group, Inc. (120K shares), and NORTHERN TRUST CORP (112K shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.